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A new insight about pharmaceutical dosage forms
for benzathine penicillin G.
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ABSTRACT
In this work, a micellar system of benzathine penicillin
G (BPG) in sodium deoxycholate (NaDC) was developed
and evaluated physicochemically. The solubility profile
of the drug in water and buffer solutions at various pH
was determined, as well as its n-octanol/water partition
coefficient. The Critical Micellar Concentration of
NaDC and its ability to incorporate BPG were also
assessed. The study was carried out at low and high
ionic strength which was adjusted by the addition of
sodium chloride. The results demonstrated the ability
of the micellar system to incorporate BPG, as well as to
increase its apparent solubility in water. The
enhancement of the solubility of BPG by the presence
of NaDC micelles could be analyzed quantitatively
within the framework of the pseudo-phase model.
Concentration analysis showed that the micellar system
could attain up to 90% incorporation of BPG. The
incorporated drug is expected to exhibit improved
stability, since the antibiotic enclosed in the hydrophobic
core of micelles is rather shielded from the aqueous
external environment.
Keywords:  Benzathine Penicillin G; micellar solubilization;
micelles; pre-formulation; sodium deoxycholate.
INTRODUCTION
Benzathine penicillin G (BPG) is natural penicillin
whose molecular structure is C48H58N6O8S.4H2O. BPG is
chemically designated as N, N-dibenzyl ethylenediamine
dipenicillin and its molecular mass is 981.19 daltons. It
occurs as a white, crystalline, odorless powder, and is very
slightly soluble in water and sparingly soluble in alcohol.
BPG concentrations are described in international units (IU),
in which 1mg corresponds to 1,211 IU of penicillin
(Shulman & Gerber, 2004). The antibacterial activity of
BPG is mainly against Gram-positive bacteria (including
actinomycetes) and some Gram-negative Cocci, as well as
some spirochetes (Parfitt, 1999). BPG is widely used in the
treatment of numerous infectious diseases, especially those
related to obstetric and gynecologic conditions. In general,
penicillin is effective in the treatment of localized skin and
soft-tissue infections of the nose, throat, lower respiratory
tract and genitourinary tract. It is also commonly used in
prevention of bacterial endocarditis prevention, prophylaxis
during gastrointestinal and/or genitourinary procedures, and
treatment of rheumatic fever (Miller, 2002).
According to the American Academy of Pediatrics,
the American Heart Association, the Infectious Diseases
Society of America and the World Health Organization the
first-line treatment for streptococcal infections consists of
monthly injections of 1,200,000 UI of BPG (Currie, 1996;
Kassem, et al., 1996). However, lack of patient compliance
has meant in treatment failure (Currie, 1996; Carapetis et
al., 2000; Peloso et al., 2003).
Sustained-release dosage forms could be a
promising means of overcoming this drawback in relation
to rheumatic fever treatment. When they are used, several
come into play (Peloso et al., 2003), for example: less
frequent dosing, improved bioavailability, reduced
concentration, increased absorption and minimization of
adverse drug reactions.
Pre-formulation studies are a preliminary stage in
the development of new drug dosage forms. Such studies
mainly focus on developing physically and chemically stable
formulations, whose biopharmaceutical profile is suitable
for their purpose. Partition coefficient analysis and solubility
tests in liquid media are some of the most important tests at
this stage (Blasco et al., 2001; Granero et al., 1999).
The drug dosage form for BPG which is currently
available on the pharmaceutical market is an intramuscular
injection suspension. Due to its variable physical properties,
such as solubility degree, viscosity and crystal size,
deviations on its bioavailability and release profile have
been reported (Currie, 1996; Carapetis et al., 2000).
Micelles and other related systems have had
considerable success in changing some of the physical and
chemical properties of drugs, e.g. solubility and stability
(Oliveira et al., 1990; Oliveira et al., 1991; Oliveira &
Chaimovich, 1993). Micellar and directly-related systems
are dynamic colloidal supramolecular aggregates containing
surfactant molecules that can efficiently dissolve water-
insoluble drug compounds (Oliveira et al., 1997; Oliveira
& Scarpa, 1999). The micelization process takes place when
the surfactant concentration exceeds the Critical Micellar
Concentration CMC (Tascioglu, 1996). This is the results
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from an induced interaction of intermolecular forces,
including electrostatic and steric repulsions, hydrogen
bonds, and Van der Waals interactions. This approach is of
particular interest in the pharmaceutical field, given the
ability of these systems to increase the solubility of
hydrophobic drugs (Rangel-Yagui et al., 2005). Besides,
this technique involves easily-controlled parameters, as the
factors that change the properties of micelles are well
established. In this study the physicochemical properties
of BPG were evaluated. The CMC was determined for
sodium deoxycholate (NaDC) in aqueous solution, as well
as its effect of sodium chloride on its CMC value. It was
aimed to develop a micellar system containing BPG, using
data obtained on ideal surfactant concentration need to
dissolve the drug.
MATERIAL AND METHODS
Determining solubility profile of drug in liquid
media is a critical stage in the development of new drug
delivery systems. In fact, the profile plays a major role in
drug dissolution, which is a rate-limiting step for drug
absorption (Blasco et al., 2001). Another major point to
consider is the analysis of the n-octanoll/water partition
coefficient. This parameter is largely used to determine the
degree of hydrophobicity in pharmacological models, as
well as to study toxic properties (Roberts, 2002). In addition
to that, it provides a theoretical approach to the partition of
molecules in biological membranes during absorption
processes.
In the study of micellar systems, the determination
of both the CMC of the surfactant and the parameters that
can modify its value are mandatory steps.
Drug Solubility Determination
In the experiments, a supersaturated solution of
BPG was used, as described in the equilibrium method
proposed by Granero et al. (1999).
Solubility in water and n-octanol
Excess of drug (250mg) was added to 5mL of
solvent (distilled water or n-octanol), and was stirred
magnetically for 24 hours at 25 oC. Afterwards, the mixture
was allowed to rest for 12 hours. As equilibrium was
reached, the samples were filtered through by using a 0.8µm
membrane and the drug concentration in the filtrate was
analyzed by UV-Vis spectrophotometry.
Solubility in different pH
The pH values of the buffer solutions varied from
5.0 to 9.0 to obtain solubilities in acid, neutral and alkaline
conditions. Samples were stirred in an ultrasound bath for
3 hours to obtain saturated solution and allowed to rest for
1.5 hour. After that, the concentration of the dissolved BPG
was determined by UV-Vis spectrophotometry.
Partition coefficient determination (log P)
This parameter was determined in n-octanol/water
mixture (Roberts, 2002; Sangster, 1997). The two phases
of solvents were stirred until equilibrium was reached, then
an accurately weighed amount of BPG dissolved in a
minimal amount of methanol was added. The mixture was
stirred for 1 hour, and allowed to rest for 36 hours for phase
separation. An aliquot of each phase was withdrawn by
pipette, and analyzed by ultraviolet spectrophotometry. The
partition coefficient was taken as the ratio of the drug
concentration (w/v) in the n-octanol and water phases,
respectively.
Determination of NaDC Critical Micellar Concentration
The CMC of sodium deoxyxcholate (NaDC) was
evaluated by determining the electric conductivity of
solutions, in which the concentration of the surfactant varied
from 0.8 to 18.1mM. The results were plotted as a function
of NaDC concentration and the CMC was taken as the point
of intersection of the curves.
To evaluate the effect of ionic strength on the
CMC, the electric conductivity of NaDC solutions was
determined in saline solutions using the same method as
for the solutions in water.
Preparation of micellar solutions of BPG
In order to prepare BPG micellar solutions a
solution of NaDC containing NaCl was used. The drug
incorporation took place under stirring in an ultrasound bath.
Macroscopic analysis was performed against black
background. Drug concentration was assessed by UV-Vis
spectrophotometry after calibration of the apparatus. The
concentration of BPG in micellar solution was established
by subtracting its concentration in the supernatant liquid
from the bulk (nominal) value.
RESULTS
The results for the solubility of the BPG in some
n-octanol, water and buffers at several pH values are
displayed in table 1, together with the n-octanol/water
partition coefficient.
Table 1.  Physicochemical properties of BPG and NaDC
micelles.
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                               BPG Solubility [mM]                 
log PWater      Octanol     pH 5.4 pH 7.4         pH 8.9
0.16            0.026        0.057 0.485            1.13              1.12
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Note that the solubility of benzathine penicillin G
in water was very low, decreasing to a value 6.2 times lower
in n-octanol (Table 1). In addition, the solubility depended
on pH increasing 8.5 fold as the pH enhanced from 5.4 to
7.4, and a further 2.3 fold from pH 7.4 to 8.9. The n-octanol/
water partition coefficient was also low.
The results of the CMC determination for sodium
deoxycholate are described in Table 2 and show clearly that
at high ionic strength due to sodium chloride concentration
of the saline solution, the value of the CMC was much lower
than in water favoring micelle formation at lower surfactant
concentrations.
Table 2.  Effect of NaCl on the Critical Micellar
Concentration of NaDC. [NaCl] = 0.09g/mL (163.63mM)
The CMC was easily determined from the
conductivity measurements at various NaDC
concentrations, since that at CMC the curve has a marked
discontinuity and a significant change in the inclination
between the straight lines (Figures 1 and 2).
Figure 1.  Determination of the Critical Micellar
Concentration of NaDC in aqueous solution. (25oC)
Figure 2.  Effect of 0.9% (w/v) sodium chloride on the
Critical Micellar Concentration of NaDC. (25oC).
Considering that in the presence of saline solution
the CMC of the NaDC was about 0.8 mM, the experimental
determination of micellar incorporation of BPG was
conducted at NADC concentrations below and above CMC
(Table 3).
Table 3.  Effect of the NaDC concentration on the
solubilization of BPG into micellar solutions in saline.
The concentration of dissolved BPG increased
with increasing surfactant concentration up to a plateau
(Figure 3). This incorporation profile is typical of micelle-
modified drug solubility where the drug solubility in the
micellar pseudo-phase is higher than that in the aqueous
phase.
Figure 3.  Effect of NaDC on the micellar incorporation
of BPG in aqueous solution containing sodium chloride
0.9 % w/v (163.63mM). See table 3 for details. Solid line
calculated from equation 1.
This increase in the solubility suggests that BPG
may be distributed between the aqueous and micellar
pseudo-phases. Then, the data in the Figure 3 can be
analyzed quantitatively by the expression of the pseudo-phase
model (Oliveira et al., 1991).
BPG
w
 + BPG
m
 . Ks . [NaDSC]
BPGd  = ——————————————               (1)
(1 + Ks) . [NaDSC]
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CMC of NaDC [mM] 
Aqueous solution
 
Saline solution
 
3.6 0.8 
BPG  
Sample 
 
NaDC (mM) 
Bulk Supernatant 
 
Abs 
Incorporation 
% w/v 
1 0.49 5.81 2.83 0.14 48.76 
2 0.98 6.01 3.51 0.15 58.33 
3 1.96 6.15 4.03 0.20 65.60 
4 2.45 5.98 5.00 0.25 83.67 
5 2.94 5.84 5.28 0.26 90.28 
6 3.92 6.32 5.63 0.28 89.10 
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Where the subscript d, w, and m refer to the
concentrations of total dissolved BPG, BPG dissolved in
the water phase and BPG dissolved in the micellar phase,
respectively. Ks is the constant that describes the
incorporation of the BPG into micellar system. The value
of BPG
w
 was obtained from the solubility of BPG in the
absence of NaDC.
The calculated value of Ks was about 106,
demonstrating clearly the incorporation of the BPG into
the micellar system.
This feature can be seen in the photographs in
Figure 4, which shows that at low surfactant concentrations,
BPG is partially dissolved, generating opaque and semi-
transparent dispersions which are completely dissolved at
high surfactant concentrations.
 
1 4 5 6 3 2 
Figure 4.  Macroscopic aspect of the system during BPG
incorporation into micellar aqueous NaDC. (1) pre-micellar
dispersion of BPG; (2-6) Stages in incorporation of BPG
into NaDC micelles at various concentrations of NADC
(see Table 1).
DISCUSSION
In the experiments of BPG solubility in different
solvents a high degree of insolubility was observed in both
lipophilic and hydrophilic media. In fact, these data agree
with those in the literature (Kreuzig, 1982), and suggest
the amphiphilic character of the drug molecule. However,
it was observed that the solubility increased with the pH
(Table 1), possibly due to the fact that BPG is an acid drug,
with the pKa of the carboxyl group around 2.65, depending
on the solvent. Thus, in the range of pH studied the
equilibrium is displaced towards ionized species, which are
fast hydrated, becoming more soluble (Atwood & Florence,
1985).
The determination of partition coefficient provided
log P for the n-octanol/water system. The low value of log
P indicates low partition capacity and medium-low
hydrophobicity. Thus, the value described in Table 1 reveals
a medium ability of the drug to diffuse to the hydrophobic
core of the micelles.
Surfactant molecules, constituted by a polar head-
group and a hydrocarbon-chain longer than eight methylene
groups, associate spontaneously in water to form dynamic
aggregates denominated micelles (Oliveira & Chaimovich,
1993). In dilute solutions below the CMC these molecules
are dispersed individually in the medium as monomers and
such solutions exhibit ideal physical and chemical
properties. As the surfactant concentration increases the
properties deviate from ideal indicating the aggregation of
monomers above the CMC forming micelles, provoking the
differentiated properties of the micellar pseudo-phase
(Tascioglu, 1996).
When the conductivity is plotted against surfactant
concentration, the data points fit on two different lines
(Figures 1 and 2). The first corresponds to concentrations
below the CMC, in which only surfactant monomers exist
in the solution (Atwood & Florence, 1985; Oliveira &
Chaimovich, 1993). At higher concentrations, micelles
appear, and conductivity curve suffers discontinuity at the
CMC. The second parte of the curve has a different slop.
The determination of the CMC was a first step in the BPG
incorporation study, used to indicate exactly the surfactant
concentration at which the micelles were formed in solution.
Addition of inorganic salts is able to change micelle
size and shape. Therefore, ionic strength influences the
solubilization rate of drugs. In fact, salt tends to reduce the
mutual electrostatic repulsion of the head groups of
surfactants, which become more hydrophobic. This effect
induces surfactant aggregation at lower concentrations. As
a result the CMC is lower and the final cost of these systems
is reduced (Tascioglu, 1996). This phenomenon was
observed here for NaDC (Figure 2), and also found to
function in BPG micellar system. The incorporation of BPG
into the micelles was feasible by a simple and fast method
that was able to increase drug incorporation markedly in
solutions above the CMC (Table 3 and Figure 3).
The value of Ks calculated from the plot of the
data by equation 1 (Ks=106) demonstrated that the
incorporation of BPG into the micellar system is due mainly
to the hydrophobic property of the drug molecule. It is
known that in several cases the effect of micelles on drug
solubility can be attributed to the free energy of activation
resulting from transfer of the substrate to a medium of lower
dielectric constant (Oliveira et al., 1991). Indeed, our results
show clearly that the solubility of BPG was increased when
the antibiotic was transferred to the low dielectric constant
medium of the hydrophobic core of the NaDC micelles. In
addition, this value for Ks is in agreement with the partition
coefficient (log P = 1.12) indicating that antibiotic molecule
is moderately lipophilic.
The determination of the analytical concentration
of the drug while [NaDC} was raised showed that the
percentage of incorporated BPG could reach about 90%
(Table 3). Hence, micellar solutions appear to be a promising
approach improving the physical-chemical properties of
BPG for therapeutic use. The dibenzyl ethylenediamine
moiety, added to penicillin G to produce BPG, delays its
release by the formation of a water-insoluble deposit at the
site of injection, due to molecular aggregation (Martinez-
Ladeira, et al., 2004).
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The incorporation of BPG into micellar systems is intended
to reduce the incompatibility of this molecule with water
(Blaha et al., 1976). Its resistance against the hydrolytic
and enzymatic degradation may be also be improved. As a
consequence, its pharmacological effect may be achieved
at lower doses. Besides, assuming that drug molecules do
not undergo degradation, they will remain
pharmacologically active for longer. The incorporation of
BPG in micellar solutions was feasible by a simple and fast
method that was also able to increase markedly the amount
of incorporated drug in solutions above the CMC. Hence,
micelle solutions seem to be a promising approach to
improving the physical-chemical properties of BPG for
therapeutic use.
RESUMO
Novas perspectivas para sistemas de liberação para a
penicilina G benzatina
O objetivo desse trabalho foi o de desenvolver e avaliar
do ponto de vista físico-químico um sistema micelar de
penicilina G benzatina (BPG) em desoxicolato de sódio
(NaDC). Foram estudadas as características físico-
químicas da BPG quanto à solubilidade em água e em
soluções tampões com diferentes pHs, além do coeficiente
de partição octanol-água. Foram avaliadas as propriedades
da concentração micelar crítica (CMC) das soluções
micelares de Desoxicolato de sódio (NaDC) em baixa e
alta força iônica provocada pela presença de cloreto de
sódio. O estudo da incorporação da BPG em soluções
micelares de NaDC usando várias concentrações de
NaDC também foi realizado. O aumento da solubilidade
da BPG provocada pela presença de micelas de NaDC
foi analisada quantitativamente pelo formalismo do
modelo de pseudo-fase. Houve indicação da
aplicabilidade do sistema micelar estudado quanto à in-
corporação de penicilina e aumento se sua solubilidade
aparente, com taxa de incorporação de até 90%. Espera-se
que a formulação micellar de BPG apresente melhor
estabilidade, considerando-se que o antibiótico incor-
porado na região hidrofóbica das micelas está protegido
do meio aquoso externo.
Palavras-chave: penicilina G benzatina; solubilização
micelar; micelas; pré-formulação; desoxicolato de sódio.
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